Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences

SAN DIEGO, Sept. 7, 2021 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that the Company will participate in the following upcoming virtual investor conferences:

H. C. Wainwright 23rd Annual Global Investment Conference
Date: On-demand session opens Monday, September 13, 2021
Time: 7:00am ET

Cantor Fitzgerald Global Healthcare Conference
Date: Monday, September 27, 2021
Time: 8:40am ET